The REVAMP trial: key questions remain

Lancet. 2024 Jan 6;403(10421):29. doi: 10.1016/S0140-6736(23)01920-7.

Authors

Qin-Yu Cai¹, Bei-Ning Deng¹, Tai-Hang Liu²

Affiliations

¹ The Joint International Research Laboratory of Reproduction and Development, Chongqing Medical University, Chongqing 400016, China.
² The Joint International Research Laboratory of Reproduction and Development, Chongqing Medical University, Chongqing 400016, China. Electronic address: liuth@cqmu.edu.cn.

PMID: 38184335
DOI: 10.1016/S0140-6736(23)01920-7

No abstract available

Publication types

Letter
Comment